15-Jul-2008 -
Appointments over the last month include a new chief research and development officer at Unilever and a sales director for Niutang UK, while the Grocery Manufacturers Association is looking for a new president.
15-Jul-2008 -
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long term strategic partnership that has been struck between the companies.
14-Jul-2008 -
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long term strategic partnership that has been struck between the companies.
01-Jul-2008 -
Lonza has scored a contract manufacturing agreement from Osiris Therapeutics for its investigational adult stem cell therapy is building a new facility to support future business activities in this area.
25-Jun-2008 -
Naturex has unveiled new websites for the branded health ingredients in its Nat'Life division, to give end consumers in Italy, Spain and Germany information on the brands in their own languages.
24-Apr-2008 -
More well-designed studies are required before any conclusions can be drawn on the benefits of omega-3 for people with bipolar disorders, University of Oxford researchers have reported after reviewing the literature.
21-Apr-2008 -
A dietary supplement ingredient for digestive health is making its comeback on the US market, with a new distribution agreement signed by B&D Nutritional Ingredients and Xsto Solutions.
08-Apr-2008 -
A rapid microbial detection kit presented as the only genetic-based test on the market to quantify yeast and mould has been launched by Switzerland's Lonza.
04-Apr-2008 -
Lonza is to expand its production of vitamin B3 in a bid to meet growing demand for the ingredient from the food industry, the company has said.
25-Mar-2008 -
Cambrex Corp, the US-based manufacturer of small-molecule active pharmaceutical ingredients (APIs) and advanced intermediates for the drug industry, has announced that one of its customers is recalling a product for which Cambrex currently supplies the API.
11-Mar-2008 -
Cobra Biomanufacturing, Crucell, Vetter, Arch Pharmalabs and Lonza have all recently announced new contract manufacturing news.
20-Feb-2008 -
Cambrex' cost cutting resolve is starting to pay off for the firm, who achieved an improved profitability in the fourth quarter of 2007, although sales are still stagnant.